Skip to content

The comparison of the efficasy of selective tibial nerve block and periarticular infiltration analgesia for total knee arthroplasty.

The comparison of the efficasy of selective tibial nerve block and periarticular infiltration analgesia for total knee arthroplasty. - The comparison of the efficasy of selective tibial nerve block and periarticular infiltration analgesia for total knee arthroplasty.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019177
Enrollment
70
Registered
2015-10-01
Start date
2014-12-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Perform selective tibial nerve block in addition to continuous femoral nerve block. Perform periarticular infiltration analgesia in addition to continuous femoral nerve block.

Sponsors

Hokkaido university. Department of anesthesiology.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients undergoing unilateral total knee arthroplasty.

Exclusion criteria

Exclusion criteria: The case the patient did not consent. The critical organ failure like impairment of liver, kidney and heart. The severe psychiatric disorder. The patients taking analgesics except for knee pain. Rheumatoid arthritis. Any case with surgical complication intraoperatively. The case of failed femoral nerve block or postoperative catheter trouble.

Design outcomes

Primary

MeasureTime frame
The postoperative pain score (VAS) in 48 hours. The frequency of additional analgesics.

Secondary

MeasureTime frame
The frequency of postoperative peroneal nerve paralysis.

Countries

Japan

Contacts

Public ContactKatsuhiro Aikawa

Hokkaido university Department of anesthesiology

katsuhiro.aikawa@gmail.com011-706-7861(+81-11-706-7861)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026